Prognosis of T1G3 tumors: Clinical factors

被引：7

作者：

Barmoshe, S ^{[1
]}

Zlotta, AR ^{[1
]}

机构：

[1] Univ Clin Brussels, Erasme Hosp, Dept Urol, B-1070 Brussels, Belgium

来源：

EUROPEAN UROLOGY SUPPLEMENTS | 2004年 / 3卷 / 03期

关键词：

D O I：

10.1016/j.eursup.2004.02.013

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：73 / 78

页数：6

相关论文

共 75 条

[1]

DIFFERING INTERPRETATIONS BY PATHOLOGISTS OF THE PT CATEGORY AND GRADE OF TRANSITIONAL CELL-CANCER OF THE BLADDER [J].

ABEL, PD ;

HENDERSON, D ;

BENNETT, MK ;

HALL, RR ;

WILLIAMS, G .

BRITISH JOURNAL OF UROLOGY, 1988, 62 (04) :339-342

[2]

RADICAL CYSTECTOMY FOR STAGE-TA, STAGE-TIS AND STAGE-T1 TRANSITIONAL-CELL CARCINOMA OF THE BLADDER [J].

AMLING, CL ;

THRASHER, JB ;

FRAZIER, HA ;

DODGE, RK ;

ROBERTSON, JE ;

PAULSON, DF .

JOURNAL OF UROLOGY, 1994, 151 (01) :31-36

[3]

MUSCULARIS MUCOSA DIFFERENTIATES 2 POPULATIONS WITH DIFFERENT PROGNOSIS IN STAGE-T1 BLADDER-CANCER [J].

ANGULO, JC ;

LOPEZ, JI ;

GRIGNON, DJ ;

SANCHEZCHAPADO, M .

UROLOGY, 1995, 45 (01) :47-53

[4]

Intravesical bacillus Calmette-Guerin treatment for stage T1 grade 3 transitional cell carcinoma of the bladder [J].

Baniel, J ;

Grauss, D ;

Engelstein, D ;

Sella, A .

UROLOGY, 1998, 52 (05) :785-789

[5]

Clinical experience with BCG alone versus BCG plus epirubicin [J].

Bilen, CY ;

Özen, H ;

Aki, FT ;

Aygün, CEM ;

Ekici, S ;

Kendi, S .

INTERNATIONAL JOURNAL OF UROLOGY, 2000, 7 (06) :206-209

[6]

BOCCONGIBOD L, 1989, EUR UROL, V16, P401

[7]

Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder [J].

Bol, MGW ;

Baak, JPA ;

Buhr-Wildhagen, S ;

Kruse, AJ ;

Kjellevold, KH ;

Janssen, EAM ;

Mestad, O ;

Ogreid, P .

JOURNAL OF UROLOGY, 2003, 169 (04) :1291-1294

[8]

Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer [J].

Bono, AV ;

Lovisolo, JA ;

Saredi, G .

EUROPEAN UROLOGY, 2000, 37 (04) :478-482

[9]

Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin [J].

Brake, M ;

Loertzer, H ;

Horsch, R ;

Keller, H .

JOURNAL OF UROLOGY, 2000, 163 (06) :1697-1701

[10]

Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies [J].

Brausi, M ;

Collette, L ;

Kurth, K ;

van der Meijden, AP ;

Oosterlinck, W ;

Witjes, JA ;

Newling, D ;

Bouffioux, C ;

Sylvester, RJ .

EUROPEAN UROLOGY, 2002, 41 (05) :523-530

← 1 2 3 4 5 6 7 8 →